The south central province of Ninh Thuan will help investors speed up the implementation of renewable energy projects, with the goal of having 2,000MW of solar power and more than 60MW of wind power connected to the grid by the end of this year, chairman of the provincial People's Committee Luu Xuan Vinh said. … [Read more...] about Ninh Thuan vows to facilitate renewable energy projects
Tech
NextTech and Next100 invest $500,000 in Chatbot Vietnam
More than 14,700 businesses have installed Bot Ban Hang and the app has attracted 10 million customers or more from five countries such as Vietnam, Taiwan, the United States, Korea, and Japan. The company attracted over 14,000 businesses and 10 million customers from Vietnam. … [Read more...] about NextTech and Next100 invest $500,000 in Chatbot Vietnam
Fortinet introduces self-learning AI appliance for sub-second threat detection
On-premises protection for air-gapped networks Another key distinction of FortiAI is that it offers on-premises AI suitable for organisations that have air-gapped networks. Operational technology environments, government agencies, and some large enterprises must adhere to strict compliance regulations and/or security policies that limit their network’s connection to the internet. FortiAI with its self-learning AI model does not require internet connectivity to learn and mature, enabling organisations with closed environments or stringent security policies to stay ahead of threats. … [Read more...] about Fortinet introduces self-learning AI appliance for sub-second threat detection
Great Bay Bio’s 3D Advisory Board Science Committee Welcomes Another New Arrival
Dr. Mark McHale received professional training in genetics, biochemistry and molecular biology at the University of London and the University of East Anglia (UEA UK). From 1986 to 1991, he obtained Ph.D. in molecular biology studying under Professor Richard Oliver and carried out post-doctoral research. Currently, he serves as the Head of R&D, Chief Development Officer and a Founder of ASLAN Pharmaceuticals. He has responsibility for progressing novel small molecule and biological therapies aimed at oncology and inflammation from preclinical development to the end of phase II of clinical trials. … [Read more...] about Great Bay Bio’s 3D Advisory Board Science Committee Welcomes Another New Arrival
